Key Highlights

  • Wingstop (NASDAQ:WING) jumped about 12% on October 28, 2026 after beating third-quarter estimates, according to the company release and published market data, while Brinker International also jumped about 12% with no verified cause.
  • Labcorp (NYSE:LH) rose 8.8% on October 28, 2026, the largest of three large-cap earnings beats outside technology. GE HealthCare gained 6.6% and PPG 4.4%, according to published market data from a single report, with no results details retrieved.
  • KLA (NASDAQ:KLAC) rose about 3% after hours on October 28, 2026 after guiding fiscal second-quarter revenue to USD 4.70 billion, plus or minus USD 200 million, about 4.7% above a USD 4.487 billion consensus.
  • Teladoc (NYSE:TDOC) rose 8% to 9% after hours on October 28, 2026 with quarterly revenue of USD 605.1 million. eBay rose 5% and Glaukos 13% in the same group of beat-and-raise reactions.

Wingstop (NASDAQ:WING): Beat with no figures retrieved

Wingstop (NASDAQ:WING) beat third-quarter estimates, according to the company release, and its shares jumped about 12% on October 28, 2026. The material reviewed did not provide the revenue or earnings per share figures, the consensus estimates or the same-store sales growth, so the margin of the beat is unknown. A beat means reported results exceeded the average analyst forecast, and a 12% reaction suggests investors saw the quality or the outlook as better than hoped. Brinker International (NYSE:EAT) moved by the same amount, but its cause was not found, so the two jumps should not be assumed to share a driver. Restaurant stocks often react strongly to a beat because the sector's results are watched as a read on consumer spending. Readers should check the release for the exact figures. Wingstop (NASDAQ:WING) operates a largely franchised model, in which independent owners run most restaurants and the company collects royalties and fees. Royalty income scales with system sales without the cost of running each store, so modest improvements in sales trends can lift profit and sentiment noticeably. Same-store sales, the change in revenue at restaurants open a year or more, is the metric investors watch most, but it was not captured in the material reviewed. The exact driver of the beat is therefore not verified.

Labcorp (NYSE:LH): Large-cap beat outside technology

Labcorp (NYSE:LH) rose 8.8% on October 28, 2026, according to published market data in one report. The same report lists GE HealthCare at 6.6% and PPG at 4.4%, and groups the three as large-cap beats outside the technology sector. These moves are confirmed in that single report, but the underlying results were not retrieved. That means the size of each earnings beat, any change to guidance and the exact time of each release are not confirmed here. The moves came on the day the Federal Reserve held rates at 3.75% to 4.00%, with Cook and Hammack preferring a hike, and the S&P 500 closed near 7,743.98. An earnings beat means reported profit came in above the consensus estimate of analysts. Shares reprice when the result changes expectations for future profit, and the move is larger when management also raises guidance. Labcorp (NYSE:LH), GE HealthCare and PPG operate in different industries, so one theme does not explain all three. What they share is a company-specific catalyst on a day when technology dominated headlines. The equal-weight S&P 500 slipped 0.04% while Technology gained 0.8%, so money rotating toward visible earnings strength outside chips is a reasonable reading, though it is an inference and not a confirmed flow of funds.

KLA (NASDAQ:KLAC): Guide above consensus

KLA (NASDAQ:KLAC) reported on October 28, 2026 and guided fiscal second-quarter revenue to USD 4.70 billion, plus or minus USD 200 million. That range runs from USD 4.50 billion to USD 4.90 billion, and even the low end sits just above the USD 4.487 billion consensus quoted in the account. Earnings per share guidance was USD 1.44 against a USD 1.36 consensus. The shares rose about 3% after hours. The data are verified in one account only, and the results for the quarter just reported were not retrieved, so this article concentrates on the forward guidance, which is what drove the move. Guidance is a forecast, so it can be revised in later quarters, up or down. Companies that make inspection and process-control tools for chip factories sell into capital spending plans, so their next-quarter guidance is read as a signal of how much chipmakers intend to invest in new equipment and in yield improvement for existing lines. Guidance above consensus tells analysts to raise estimates, which usually lifts the share price at once, while guidance below does the reverse. The reaction here arrived within a wider chip rally: SK hynix ADR rose 13.3% and Vertiv rose 16.5% in the same period, while Marvell fell 9.4% on reported talks with Lumentum.

Teladoc (NYSE:TDOC): Beat-and-raise reaction

Teladoc (NYSE:TDOC) rose 8% to 9% after hours on October 28, 2026, and its quarterly revenue was USD 605.1 million. The same trading session saw eBay rise 5% on earnings per share of USD 1.51 and Glaukos rise 13%. Bausch Health and GFL Environmental also jumped, though the gains were not sized in the account used here. The moves are verified in published market data, but the full results and any guidance changes behind them were not retrieved. The range of 8% to 9% for Teladoc reflects different quotes taken at different minutes, which is common when after-hours trading is thin and prices move with each new order. A beat-and-raise combines two events: reported results above the analyst consensus and a higher outlook for coming quarters. Investors often pay more for the second part, because raised guidance lifts estimates for several periods rather than just one. The companies here sit in different industries, from digital health and online marketplaces to eye-care devices, so the common thread is results rather than sector news. For Teladoc (NYSE:TDOC), a digital health services provider, revenue of USD 605.1 million matters mainly against what analysts expected, and that consensus figure was not retrieved.

Where Things Stand

The answer is that each stock rose on company news that beat expectations, not on policy news. Wingstop (NASDAQ:WING) beat third-quarter estimates. Labcorp (NYSE:LH) led three beats outside technology. KLA (NASDAQ:KLAC) guided above consensus. Teladoc (NYSE:TDOC) was received as beat and raise. The size of most beats was not retrieved, so the quality of each result cannot yet be judged. The next test is the October 29 open. This is not investment advice.